Chugai Pharmaceutical Co Ltd (CHGCY)
16.62
+0.16
(+0.97%)
USD |
OTCM |
May 03, 16:00
Chugai Pharmaceutical Price to Book Value: 5.041 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 5.041 |
| May 02, 2024 | 4.993 |
| May 01, 2024 | 4.814 |
| April 30, 2024 | 4.805 |
| April 29, 2024 | 4.747 |
| April 26, 2024 | 4.665 |
| April 25, 2024 | 4.729 |
| April 24, 2024 | 4.862 |
| April 23, 2024 | 5.093 |
| April 22, 2024 | 5.047 |
| April 19, 2024 | 4.820 |
| April 18, 2024 | 4.938 |
| April 17, 2024 | 4.959 |
| April 16, 2024 | 5.032 |
| April 15, 2024 | 4.941 |
| April 12, 2024 | 5.023 |
| April 11, 2024 | 5.189 |
| April 10, 2024 | 5.138 |
| April 09, 2024 | 5.372 |
| April 08, 2024 | 5.375 |
| April 05, 2024 | 5.457 |
| April 04, 2024 | 5.505 |
| April 03, 2024 | 5.596 |
| April 02, 2024 | 5.527 |
| April 01, 2024 | 5.696 |
| Date | Value |
|---|---|
| March 31, 2024 | |
| March 28, 2024 | 5.461 |
| March 27, 2024 | 5.582 |
| March 26, 2024 | 5.595 |
| March 25, 2024 | 5.515 |
| March 22, 2024 | 5.512 |
| March 21, 2024 | 5.567 |
| March 20, 2024 | 5.772 |
| March 19, 2024 | 5.761 |
| March 18, 2024 | 5.864 |
| March 15, 2024 | 5.752 |
| March 14, 2024 | 5.841 |
| March 13, 2024 | 5.995 |
| March 12, 2024 | 6.232 |
| March 11, 2024 | 6.272 |
| March 08, 2024 | 6.263 |
| March 07, 2024 | 6.175 |
| March 06, 2024 | 6.129 |
| March 05, 2024 | 5.961 |
| March 04, 2024 | 5.938 |
| March 01, 2024 | 5.829 |
| February 29, 2024 | 5.687 |
| February 28, 2024 | 5.638 |
| February 27, 2024 | 5.681 |
| February 26, 2024 | 5.681 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.663
Minimum
Mar 01 2023
11.42
Maximum
Jun 29 2020
6.045
Average
5.480
Median
Dec 30 2021
Price to Book Value Benchmarks
| Takeda Pharmaceutical Co Ltd | 0.8775 |
| Nxera Pharma Co Ltd | 1.803 |
| PeptiDream Inc | 5.939 |
| Stemcell Holdings Inc | -- |
| Healios KK | 3.273 |
Price to Book Value Related Metrics
| PE Ratio | 24.18 |
| PS Ratio | 7.612 |
| Price to Free Cash Flow | 24.56 |
| Price | 16.62 |
| Earnings Yield | 4.14% |
| Market Cap | 54.69B |
| Operating PE Ratio | 17.90 |
| Normalized PE Ratio | 24.18 |